Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8401 to 8415 of 8908 results

  1. Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]

    Discontinued Reference number: GID-HST10038

  2. Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]

    Discontinued Reference number: GID-HST10004

  3. Heart failure: beta blockers (IND194)

    This indicator has been updated and replaced by NICE indicator 317.

  4. Heart Failure: ACEi or ARBs (IND193)

    This indicator has been updated and replaced by NICE indicator 317.

  5. Asthma: annual review (IND188)

    This guidance has been updated and replaced by NICE indicator 273.

  6. Asthma: objective tests (IND187)

    This guidance has been updated and replaced by NICE indicator 272.

  7. Diabetes: statins for secondary prevention of CVD (IND184)

    This guidance has been updated and replaced by NICE indicator 276.

  8. Diabetes: statins for primary prevention of CVD (40 years and over) (IND183)

    This guidance has been updated and replaced by NICE indicator 275.

  9. Diabetes: statins for primary prevention of CVD (T2DM and 10% risk) (IND182)

    This guidance has been updated and replaced by NICE indicator 274.

  10. Atrial fibrillation: pulse rhythm assessment in people at risk (IND168)

    This indicator has been withdrawn following National Screening Committee recommendations and ongoing research.

  11. Weight management: BMI calculation in preceding 5 years (IND167)

    This indicator has been withdrawn following discussions with the National Screening Committee.

  12. Diabetes: T1DM and statins (IND166)

    This guidance has been updated and replaced by NICE indicator 277.

  13. Weight management: BMI recording (long-term conditions) (IND151)

    This indicator has been updated and replaced by NICE indicator 320.